MassBio’s Annual Meeting is now the State of Possible Conference, where we’ll celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. We’ve invited the best and brightest to share their insights with our attendees, and already have an impressive lineup of speakers. Meet a few of our speakers below!
Did you know Katrine Bosley, immediate past CEO of Editas Medicine…
Became the first CEO for Avila Therapeutics in 2009 and successfully sold the company to Celgene in 2012.
Was named Top 10 Women in Biotech by FierceBiotech.
Led Editas Medicine’s $94 million IPO in 2016, making it the first ever publicly traded CRISPR-Cas9 drug developer.
Did you know George M. Church, Professor of Genetics at Harvard Medical School…
Has co-founded more than 14 biotech companies.
Pioneered the use of the enzyme CRISPR to edit the genes of human cells.
Has coauthored 450 papers, 105 patents, and one book, “Regenesis”.
Did you know Laura Indolfi, Founder & CEO of PanTher Therapeutics…
Was one of five women selected by the Massachusetts Life Science Center and Takeda for their 2018 class for the MassNextGen program, an initiative to ensure greater gender parity in the next generation of life science entrepreneurs.
Graduated from MassBio’s MassCONNECT mentoring program.
Is a TED Fellow, one of 21 people chosen annually by the TED organization who are considered to be the most disruptive and transformative change-makers in the world.
Did you know John Maraganore, CEO of Alnylam…
Serves as Chair of the Board of Directors at the Biotechnology Innovation Organization (BIO).
Called out President Trump for his remarks about Haiti and some African countries tweeting, ““My Mom and Dad came to this country from what was then a ‘s***hole.’ They loved this country. I’m proud to be a ‘s***holer!’”
Is not only the son of Greek immigrants but is also the child of a physician and a nurse.
See more speakers here and register today!